Literature DB >> 31612823

Extracellular Vesicles as Therapeutics for Brain Injury and Disease.

Dinesh Upadhya1, Ashok K Shetty2.   

Abstract

Extracellular vesicles (EVs) are gaining tremendous importance in comprehending central nervous system (CNS) function and treating neurological disorders because of their role in intercellular communication and reparative processes, and suitability as drug delivery vehicles. Since EVs have lipid membranes, they cross the blood-brain barrier easily and communicate with target neurons and glia even deep inside the brain. EVs from various sources have been isolated, characterized, and tailored for promoting beneficial effects in conditions, such as brain injury and disease. Particularly, EVs isolated from mesenchymal stem cells and neural stem cells have shown promise for alleviating brain dysfunction after injury or disease. Such properties of stem cell-derived EVs have great importance for clinical applications, as EV therapy can avoid several concerns typically associated with cell therapy. This minireview confers the competence of EVs for improving brain function by modulating CNS injury and disease. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Brain injury; exosomes; extracellular vesicles; mesenchymal stem cells; neural stem cells; neurodegenerative diseases.

Mesh:

Year:  2019        PMID: 31612823     DOI: 10.2174/1381612825666191014164950

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Biogenesis of Extracellular Vesicles.

Authors:  Taeyoung Kang; Ishara Atukorala; Suresh Mathivanan
Journal:  Subcell Biochem       Date:  2021

Review 2.  Insights of Extracellular Vesicles of Mesenchymal Stem Cells: a Prospective Cell-Free Regenerative Medicine for Neurodegenerative Disorders.

Authors:  P Vatsa; R Negi; U A Ansari; V K Khanna; A B Pant
Journal:  Mol Neurobiol       Date:  2021-10-29       Impact factor: 5.682

3.  Proficiency of Extracellular Vesicles From hiPSC-Derived Neural Stem Cells in Modulating Proinflammatory Human Microglia: Role of Pentraxin-3 and miRNA-21-5p.

Authors:  Raghavendra Upadhya; Leelavathi N Madhu; Shama Rao; Ashok K Shetty
Journal:  Front Mol Neurosci       Date:  2022-05-17       Impact factor: 6.261

Review 4.  Astrocyte-derived extracellular vesicles: Neuroreparative properties and role in the pathogenesis of neurodegenerative disorders.

Authors:  Raghavendra Upadhya; Winston Zingg; Siddhant Shetty; Ashok K Shetty
Journal:  J Control Release       Date:  2020-04-11       Impact factor: 9.776

Review 5.  Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.

Authors:  K R Sabitha; Ashok K Shetty; Dinesh Upadhya
Journal:  Neurosci Biobehav Rev       Date:  2020-12-25       Impact factor: 8.989

Review 6.  Native and Bioengineered Exosomes for Ischemic Stroke Therapy.

Authors:  Haroon Khan; Jia-Ji Pan; Yongfang Li; Zhijun Zhang; Guo-Yuan Yang
Journal:  Front Cell Dev Biol       Date:  2021-03-23

Review 7.  Mitochondrial Extracellular Vesicles in CNS Disorders: New Frontiers in Understanding the Neurological Disorders of the Brain.

Authors:  Mary F Nakamya; Susmita Sil; Shilpa Buch; Ramin M Hakami
Journal:  Front Mol Biosci       Date:  2022-03-30

8.  Proinflammatory Extracellular Vesicle-Mediated Signaling Contributes to the Induction of Neuroinflammation in Animal Models of Endotoxemia and Peripheral Surgical Stress.

Authors:  F Fricke; J Gebert; J Kopitz; K Plaschke
Journal:  Cell Mol Neurobiol       Date:  2020-06-18       Impact factor: 5.046

9.  Intranasally Administered Human MSC-Derived Extracellular Vesicles Pervasively Incorporate into Neurons and Microglia in both Intact and Status Epilepticus Injured Forebrain.

Authors:  Maheedhar Kodali; Olagide W Castro; Dong-Ki Kim; Alicia Thomas; Bing Shuai; Sahithi Attaluri; Raghavendra Upadhya; Daniel Gitai; Leelavathi N Madhu; Darwin J Prockop; Ashok K Shetty
Journal:  Int J Mol Sci       Date:  2019-12-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.